ECSS
WST icon

Eurizon Capital SGR SpA’s West Pharmaceutical WST Stock Holding History

Eurizon Capital SGR SpA’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Buy
15,452
+2,825
+22% +$864K 0.01% 414
2026
Q1 		$3.16M Buy
+12,627
New +$3.14M 0.01% 481

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Eurizon Capital SGR SpA's WST Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its West Pharmaceutical (WST) stake by 22% in Q2 2026, buying an estimated $864K and bringing the position to 15,452 shares worth $5.55M. The position accounts for 0.01% of the portfolio, ranked #414.

Eurizon Capital SGR SpA first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Eurizon Capital SGR SpA held 15,452 shares of West Pharmaceutical worth $5.55M as of Q2 2026.
  • Eurizon Capital SGR SpA bought 2,825 West Pharmaceutical shares in Q2 2026, an estimated $864K.
  • West Pharmaceutical made up 0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #414 holding.
  • Eurizon Capital SGR SpA first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.